ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q2SCImago #7,235Hybrid

Epigenomics

Abbreviation (ISO):EPIGENOMICS-UK
•
Identifier (ISSN):1750-1911(Print)/1750-192X(Online)
•
Publisher:Future Medicine Ltd.
Clarivate IF (2026)
3.1↑ +0.5
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Epigenomics

WoS Q2
13574.9820184.420194.1120204.7820214.3620223.82023320242.620253.12026
Annual Impact Factor Metric
Current (2026):3.1
Scopus SJR & RankScopus Q2
0.774
#7,235

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
85

85 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate6.7%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
110articles/year
13.74% Gold OA•74.29% Original Research

Aims & Scope

Epigenomics provides the forum to address the rapidly progressing research developments in this ever-expanding field; to report on the major challenges ahead and critical advances that are propelling the science forward. The journal delivers this information in concise, at-a-glance article formats – invaluable to a time constrained community. Substantial developments in our current knowledge and understanding of genomics and epigenetics are constantly being made, yet this field is still in its infancy. Epigenomics provides a critical overview of the latest and most significant advances as they unfold and explores their potential application in the clinical setting.

Topics Covered (Recognized by AI)
BiologyGeneticsBiochemistryChemistryMedicineInternal MedicineDNAComputational BiologyBioinformaticsCancer ResearchPathologyOncology & Cancer Research
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

GENETICS & HEREDITY

Q2
Rank74/192
IndexSCIE
JCISCIE2026

GENETICS & HEREDITY

Q3
Rank101/192
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.1
Articles / Year81
Total Citations26
2025
IF2.6
Articles / Year127
Total Citations336
2024
IF3
Articles / Year113
Total Citations643
2023
IF3.8
Articles / Year108
Total Citations811
2022
IF4.357
Articles / Year106
Total Citations1,047

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #7,235Scopus Q2SCImago Profile
Scopus Coverage:2009-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular Biology
Scopus Citation Rank (SJR)Q2
0.774

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
2.51

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,183 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations804
3-Year Documents329
Citable Documents288

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate52.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

GeneticsQ2
Cancer ResearchQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 6.7%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区GENETICS & HEREDITY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Epigenomics (abbr: EPIGENOMICS-UK, ISSN: 1750-1911) is a peer-reviewed international scholarly journal in the field of GENETICS & HEREDITY, published by Future Medicine Ltd. in England since 2009. The periodical holds a Journal Impact Factor (JIF) of 3.10, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.774 (Q2), an H-index of 85.

The journal enforces rigorous peer evaluation with an annual output of approximately 110 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,183 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Future Medicine Ltd.
Publication Language
English
Frequency
Periodic
Founding Year
2009
Indexing & Databases
SCIEScopusPubMed
Editorial Address
UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, ENGLAND, N3 1QB

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 404d81ca-aa27-4631-b94c-c8a607055230
Database Updated: 2026-09-28